Dividend Alert: Will Nov 2, 2016 be the day West Pharmaceutical Services, Inc. (NYSE:WST) makes dividends of $0.13?

October 16, 2016October 16, 2016Linda Rogers

West Pharmaceutical Services, Inc. (NYSE:WST) is expected to pay $0.13 on Nov 2, 2016. The indicated annual dividend is $0.52. Shareholders owning the stock before Oct 17, 2016 will be eligible to receive the payout. Based on West Pharmaceutical Services, Inc.’s current price of $72.84, the dividend is 0.18%. This dividend’s record date is Oct 19, 2016 and the announcement date is Sep 12, 2016. The stock decreased 0.31% or $0.23 on October 14, hitting $72.84. About 238,624 shares traded hands. West Pharmaceutical Services Inc. (NYSE:WST) has risen 12.30% since March 14, 2016 and is uptrending. It has outperformed by 6.69% the S&P500.

West Pharmaceutical Services, Inc. is a maker of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The company has a market cap of $5.32 billion. The Company’s divisions include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). It has a 53.36 P/E ratio. The Company’s Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components.

Insitutional Activity: The institutional sentiment increased to 1.11 in 2016 Q2. Its up 0.01, from 1.1 in 2016Q1. The ratio is positive, as 15 funds sold all West Pharmaceutical Services Inc. shares owned while 102 reduced positions. 51 funds bought stakes while 79 increased positions. They now own 65.20 million shares or 3.67% less from 67.68 million shares in 2016Q1.
Veritable Lp holds 0.01% or 4,455 shares in its portfolio. Arizona State Retirement Sys holds 0.03% or 31,136 shares in its portfolio. National Bank Of Montreal Can accumulated 4,066 shares or 0% of the stock. Sg Americas Limited Liability Co has 21,154 shares for 0.01% of their US portfolio. State Bank Of New York Mellon accumulated 795,239 shares or 0.02% of the stock. Mufg Americas Hldg accumulated 668 shares or 0% of the stock. The New Jersey-based Nj State Employees Deferred Compensation Plan has invested 0.48% in West Pharmaceutical Services Inc. (NYSE:WST). The New York-based Mutual Of America Cap Mngmt Limited Liability has invested 0.11% in West Pharmaceutical Services Inc. (NYSE:WST). Century Cos accumulated 0.07% or 857,188 shares. Guggenheim Cap Ltd owns 7,962 shares or 0% of their US portfolio. Cornerstone Mgmt Limited Liability has invested 0% of its portfolio in West Pharmaceutical Services Inc. (NYSE:WST). New York State Common Retirement Fund holds 0.02% of its portfolio in West Pharmaceutical Services Inc. (NYSE:WST) for 149,016 shares. The Connecticut-based Trexquant Invest Ltd Partnership has invested 0.04% in West Pharmaceutical Services Inc. (NYSE:WST). The New York-based Bamco Inc Ny has invested 0.92% in West Pharmaceutical Services Inc. (NYSE:WST). Voya Investment Mngmt Ltd Limited Liability Company holds 31,127 shares or 0.01% of its portfolio.

Insider Transactions: Since May 25, 2016, the stock had 0 insider purchases, and 4 insider sales for $1.94 million net activity. The insider Hofmann Thomas W sold $181,432. On Tuesday, September 6 the insider Flynn Karen sold $1.21M. On Thursday, June 2 the insider Malone Daniel sold $296,057. 3,042 shares were sold by Johnson Paula A, worth $248,075.

West Pharmaceutical Services Inc. (NYSE:WST) Ratings Coverage

Out of 2 analysts covering West Pharmaceutical Services (NYSE:WST), 1 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 50% are positive. West Pharmaceutical Services has been the topic of 4 analyst reports since August 4, 2015 according to StockzIntelligence Inc. The stock has “Hold” rating given by Zacks on Tuesday, August 4. The firm has “Outperform” rating by Wells Fargo given on Tuesday, March 22. The firm has “Market Perform” rating by Wells Fargo given on Wednesday, September 21. Janney Capital initiated the shares of WST in a report on Friday, January 8 with “Buy” rating.

More important recent West Pharmaceutical Services Inc. (NYSE:WST) news were published by: Nasdaq.com which released: “West Pharmaceutical Services, Inc. (WST) Ex-Dividend Date Scheduled for …” on October 14, 2016, also Prnewswire.com published article titled: “West Appoints David A. Montecalvo Senior Vice President, Global Operations and …”, Prnewswire.com published: “West Elects New Director and Announces Increase to Quarterly Dividend” on September 12, 2016. More interesting news about West Pharmaceutical Services Inc. (NYSE:WST) was released by: Forbes.com and their article: “RSI Alert: West Pharmaceutical Services (WST) Now Oversold” with publication date: September 22, 2016.

WST Company Profile

West Pharmaceutical Services, Inc. (West), incorporated on July 27, 1923, is a maker of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s divisions include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). The Company’s products include stoppers and seals for vials, and contract design and manufacturing services. The Company’s clients include producers of pharmaceuticals, biologics, medical devices and consumer products.